Observational studyNature communications2022

Third primary SARS-CoV-2 mRNA vaccines enhance antibody responses in most patients with haematological malignancies.

Lucy B Cook et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.